POCT (Point-od-Care-Testing) even though the test is also known as “bedside testing”, is the use of portable analytical instruments and supporting reagents to quickly get the test results of a test, as a major category of in vitro diagnostics, POCT products by virtue of the operation is simple to break through the restrictions of the site, As a major category of in vitro diagnostics, POCT products are widely used in many scenarios, such as grassroots outpatient clinics, emergency centers, and home consumption, etc. POCT products are widely sought after due to their immediate and convenient advantages.The global POCT industry market size grew at a compound annual growth rate of about 12% during 2016-2021, and the global POCT market size is expected to reach USD 30 billion in 2022. The domestic POCT market started late, the overall market size is small, and the penetration rate of terminal scenes such as hospitals is low, thus the potential development space is huge. According to statistics, the domestic POCT market size accounts for more than 10% of the overall in vitro diagnostics market, with a growth rate of more than 20%, which is one of the faster-growing segments in the in vitro diagnostics industry.The market size in 2021 increased to about 2.6 billion U.S. dollars, with a year-on-year growth rate of 20.9%, and it is expected that the market size in China in 2022 will exceed 3.1 billion U.S. dollars. From the perspective of market segmentation, blood glucose monitoring and infectious diseases are the two main application areas of POCT globally, with market shares of 44% and 31% respectively in 2021. At present, multinational giants still dominate China's POCT market, with foreign brands accounting for more than 60%, and the market share of domestic enterprises needs to be further improved.
language
